Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.
Hims & Hers Health, Inc. reports news about its consumer telehealth platform, which connects customers with providers and offers treatment options across areas such as sexual health, hair loss, skin care, mental health and weight loss. Company updates commonly cover prescription access, FDA-approved GLP-1 weight loss medications, platform memberships, subscriber benefits and health-and-wellness partner programs.
Recurring developments also include operating and financial results, conference participation, board and executive appointments, shareholder voting matters, governance updates and clinical or regulatory disclosures tied to products available through the Hims and Hers platform.
Hims & Hers Health, a telehealth platform, will participate in the Citi 2021 Healthcare Services Conference on February 25, 2021, at 3:20 p.m. E.T. CEO Andrew Dudum will lead a fireside chat during the event. Their services cover primary care, mental health, sexual health, and dermatology across all 50 states. Launched in November 2017, Hims & Hers offers accessible and affordable healthcare solutions. The audio webcast and related materials will be available online.
Hims & Hers Health, Inc. (NYSE: HIMS) will release its fiscal fourth quarter and full year 2020 financial results on March 18, 2021, after market close. A conference call will follow at 5:00 p.m. E.T. Investors can join by dialing (833) 900-2256 for U.S. participants or (236) 714-2727 for international participants, using conference ID #3380049. The call will also be available via a live audio webcast, and a replay will be accessible shortly after the event. Hims & Hers is a telehealth platform, providing access to licensed healthcare professionals across numerous medical conditions.